quality-adjusted life years

Ask MedXY AI

Latest news

Tag

General SurgeryCost-Effectivenessquality-adjusted life years

Cost-effectiveness of Robotic Versus Open Pancreatoduodenectomy: Insights from the DIPLOMA-2 Multicenter Randomized Trial

By MedXY|Aug 17, 2026

This randomized trial analysis compares the costs and quality-adjusted life years of robotic versus open pancreatoduodenectomy, revealing no significant cost differences but a lower probability that robotic surgery is cost-effective at six

Clinical Updatescardiovascular diseaseCost-Effectiveness

Cost-Effectiveness Analysis of Menopausal Hormone Therapy: Integrating Risk-Benefit Profiles and Economic Models

By MedXY|Aug 18, 2026

This review synthesizes current evidence on menopausal hormone therapy’s cost-effectiveness, highlighting findings from a 2026 Markov model analysis and contextualizing with pivotal studies on health outcomes and economic implications